U.S. Nicotinamide Adenine Dinucleotide (Nad) Products Market Size & Outlook
The nicotinamide adenine dinucleotide (nad) products market in the United States is expected to reach a projected revenue of US$ 1,768.3 million by 2033. A compound annual growth rate of 12.2% is expected of the United States nicotinamide adenine dinucleotide (nad) products market from 2025 to 2033.
- Food Beverages & Tobacco
- Supplements & Nutrition
- Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook
- Supplements & Nutrition
Revenue, 2024 (US$M)
$622.2
Forecast, 2033 (US$M)
$1,768.3
CAGR, 2025 - 2033
12.2%
Report Coverage
U.S.
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the nicotinamide adenine dinucleotide (nad) products market
Every figure cited from GVR research
U.S. nicotinamide adenine dinucleotide (nad) products market highlights
- The U.S. nicotinamide adenine dinucleotide (nad) products market generated a revenue of USD 622.2 million in 2024 and is expected to reach USD 1,768.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 12.2% from 2025 to 2033.
- In terms of segment, oral supplements was the largest revenue generating product in 2024.
- Topical Products is the most lucrative product segment registering the fastest growth during the forecast period.
Nicotinamide adenine dinucleotide (nad) products market data book summary
| Market revenue in 2024 | USD 622.2 million |
| Market revenue in 2033 | USD 1,768.3 million |
| Growth rate | 12.2% (CAGR from 2025 to 2033) |
| Largest segment | Oral supplements |
| Fastest growing segment | Topical Products |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral Supplements, Topical Products, Others(NAD Injections, NAD IV, Nad Nasal Spray) |
Other key industry trends
- In terms of revenue, U.S. accounted for 18.0% of the global nicotinamide adenine dinucleotide (nad) products market in 2024.
- Country-wise, China is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. nicotinamide adenine dinucleotide (nad) products market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 76.3 million by 2033.
No credit card required*
Publish Date: Oct 28, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nicotinamide Adenine Dinucleotide (NAD) Products Market Scope
Nicotinamide Adenine Dinucleotide (NAD) Products Market segmentation & scope
Nicotinamide Adenine Dinucleotide (NAD) Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Life Extension | View profile | 251-500 | Fort Lauderdale, Florida, United States, North America | www.lifeextension.com/ |
| Renue By Science | View profile | - | Jacksonville, Florida, United States, North America | renuebyscience.com/ |
| Nutricost | View profile | 101-250 | Orem, Utah, United States, North America | nutricost.com |
| Thorne Research Inc. | View profile | 251-500 | New York, New York, United States, North America | www.thorne.com |
| Codeage LLC | View profile | - | - | - |
| Niagen Bioscience | View profile | 101-250 | Los Angeles, California, United States, North America | www.niagenbioscience.com/ |
| Elysium | View profile | 11-50 | New York, New York, United States, North America | www.elysiumhealth.com |
| Cata-Kor | View profile | 1-10 | Wilmington, Delaware, United States, North America | www.catakor.com |
| Wonderfeel Biosciences | View profile | 11-50 | San Francisco, California, United States, North America | www.getwonderfeel.com |
| HPN+ | View profile | 101-250 | Gronau, Nordrhein-Westfalen, Germany, Europe | hpnplus.de/ |
U.S. Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook will help companies and investors design strategic landscapes.
Oral Supplements was the largest segment with a revenue share of 77.13% in 2024.
Horizon Databook has segmented the U.S. nicotinamide adenine dinucleotide (nad) products market based on oral supplements, topical products, others(nad injections, nad iv, nad nasal spray) covering the revenue growth of each sub-segment from 2021 to 2033.
- U.S. Nicotinamide Adenine Dinucleotide (Nad) Products Market Product Outlook (Revenue, USD Million , 2021-2033)
- Oral Supplements
- Topical Products
- Others
- U.S. Nicotinamide Adenine Dinucleotide (Nad) Products Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hypermarkets & Supermarkets
- Pharmacies & Drug Stores
- Online
- Others
Reasons to subscribe to Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook databook
- Our clientele includes a mix of Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Nicotinamide Adenine Dinucleotide (Nad) Products Market, 2021-2033 (US$M)
US Product - Nicotinamide Adenine Dinucleotide (nad) Products Market Statistics, 2024 - 2033 (US$M)
